ReviewDiabetologia2019
What should governments be doing to prevent diabetes throughout the life course?
Review in Diabetologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Physical activity as clinical practice care for patients with type 2 diabetics and its implementation in routine clinical care: an expert opinion survey.Frontiers in endocrinology · 2025Article
- Quality priorities related to the management of type 2 diabetes in primary care: results from the COMPAS + quality improvement collaborative.BMC primary care · 2024Article
- Article
- Lifestyle and metabolic risk factors, and diabetes mellitus prevalence in European countries from three waves of the European Health Interview Survey.Scientific reports · 2024Article
- Article
- Food & You: A digital cohort on personalized nutrition.PLOS digital health · 2023Article
- Diabetes risk and provision of diabetes prevention activities in 44 low-income and middle-income countries: a cross-sectional analysis of nationally representative, individual-level survey data.The Lancet. Global health · 2023Article
- Poor glycemic control and associated factors among patients with type 2 diabetes mellitus: a cross-sectional study.Scientific reports · 2023Article
- A multiple case study of pre-diabetes care undertaken by general practice in Aotearoa/New Zealand: de-incentivised and de-prioritised work.BMC primary care · 2023Article
- General Public's Knowledge of Diabetes and Physical Activity in Saudi Arabia over Time: The Need to Refresh Awareness Campaigns.Healthcare (Basel, Switzerland) · 2023Article
- Neighborhood Conditions and Type 2 Diabetes Risk among Latino Adolescents with Obesity in Phoenix.International journal of environmental research and public health · 2022Article
- Video-based smartphone app ('VIDEA bewegt') for physical activity support in German adults: a single-armed observational study.BMJ open · 2022Observational
- Lifestyle and socioeconomic determinants of diabetes: Evidence from country-level data.PloS one · 2022Article
- How the European Union legislations are tackling the burden of diabetes mellitus: A legal surveillance study.Frontiers in public health · 2022Article
- COVID-19 and metabolic disease: mechanisms and clinical management.The lancet. Diabetes & endocrinology · 2021Review
- Impact of Policies in Nutrition and Physical Activity on Diabetes and Its Risk Factors in the 28 Member States of the European Union.Nutrients · 2021Article
- Review
- Physical Activity of Type 2 Diabetes Mellitus Patients and Non-Diabetes Participants in Yangon, Myanmar: A Case-Control Study Applying the International Physical Activity Questionnaires (IPAQ-S).Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- [Media coverage of prevention and treatment options using the examples of diabetes mellitus and depression].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Health systems and governments are increasingly required to implement measures that target at-risk populations to prevent noncommunicable diseases. In this review we lay out what governments should be doing to prevent diabetes throughout the life course. The following four target groups were used to structure the specific recommendations: (1) pregnant women and young families, (2) children and adolescents, (3) working age population, and (4) the elderly. The evidence to date supports the effectiveness of some known government policy measures, such as sugar taxes and regulatory measures in the (pre-)school setting for children and adolescents. Many of these appear to be more effective if they are part of a bundle of strategies and if they are supplemented by communication strategies. Although there is a current focus on strategies that target the individual, governments can make use of evidence-based population-level prevention strategies. More research and continuous evaluation of the overall and subgroup-specific effectiveness of policy strategies using high-quality longitudinal studies are needed.
Indexed as
Identifiers
31451873What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.